Myat Myint, MD

Myat Myint, MD, is a board eligible endocrinologist. Dr. Myint has specific training in management of diabetes mellitus, diabetes technologies including continuous glucose monitoring system and insulin pump therapy, thyroid disorders, thyroid cancer, thyroid ultrasound and thyroid biopsies, and other endocrine disorders. One of her specific goals is to optimally manage the metabolic diseases thereby reducing and preventing the adverse cardiovascular events and other consequences. She is also board-certified by the American Board of Internal Medicine (ABIM). She has an extensive medical background and strong experience in serving a very diverse population in New York City and West Florida obtained during her residency and fellowship training. In her spare time, Dr. Myint enjoys home decorating and traveling.

The conditions Dr. Myint treats include:

•  
• Diabetes mellitus
• Thyroid disorders
• Parathyroid and metabolic bone disease
• Adrenal disorders
• Pituitary disorders
• Lipid management 
• Hypogonadism
• Obesity

Languages: Burmese, English

Certification: American Board of Internal Medicine

Professional School: University of Medicine 1, Yangon, Myanmar

Residency: Brookdale University Hospital and Medical Center, Internal Medicine (Brooklyn, NY)

Fellowship: HCA Healthcare - USF Morsani, College of Medicine (Tampa, FL); HCA Florida Bayonet Point Hospital (Hudson, FL)

Medical Groups: MultiCare, MultiCare Medical Associates

Research:

• Screening of Primary Aldosteronism with Low-threshold Criteria in an Outpatient Clinic Setting (research abstract publication at Journal of Endocrine Society).
• Hyperandrogenism Caused by a Steroid Cell Tumor of the Ovary in a Postmenopausal Woman (case report publication at Journal of Endocrine Society).
• A Rare Disease Engulfing Thyroid And Masquerading As Common Thyroid Disorders (case report publication at Journal of Endocrine Society Nov 1, 2022).
• Study of Patients’ Characteristics and Mutual Impact Between Covid-19 and Hyperglycemia at a Community Hospital in Central Brooklyn (research abstract publication at Journal of Endocrine Society May 3, 2021).
• A Case of Autoimmune Hypoglycemia (Insulin Autoimmune Syndrome) (case report publication at Journal of Endocrine Society May 3, 2021).